Predicting breast cancer risk through testing BRCA1 and BRCA2 high‐risk variants seen in our populations represents a genetic screening paradigm shift to a broader definition of population screening to include predisposition screening (Lieberman et al. This evidence concerns the gene BRCA1 and breast carcinoma.